Issued Patents All Time
Showing 25 most recent of 27 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| RE49556 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2023-06-20 |
| 10576080 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2020-03-03 |
| 10568884 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2020-02-25 |
| 10005761 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2018-06-26 |
| 9850229 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2017-12-26 |
| 9850230 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2017-12-26 |
| 9593099 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2017-03-14 |
| 9593100 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2017-03-14 |
| 9314464 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2016-04-19 |
| 9181238 | N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors | Shifeng Pan, John Tellew, Yongqin Wan, Yongping Xie, Xing Wang +3 more | 2015-11-10 |
| 8859548 | Compounds and compositions as protein kinase inhibitors | Abran Q. Costales, Jeff Jin, Zuosheng Liu, Sabina Pecchi, Daniel Poon +2 more | 2014-10-14 |
| 8563553 | Compounds and compositions as protein kinase inhibitors | Abran Q. Costales, Jeff Jin, Zuosheng Liu, Sabina Pecchi, Daniel Poon +1 more | 2013-10-22 |
| 8501758 | Compounds and compositions as protein kinase inhibitors | Xianming Jin, Zuosheng Liu, Daniel Poon, John Tellew, Yongqin Wan +2 more | 2013-08-06 |
| 8299082 | 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives | Ronghui Lin, Peter J. Connolly, Stuart Emanuel, Steven A. Middleton, Robert H. Gruninger +1 more | 2012-10-30 |
| 8242260 | Compounds and compositions as protein kinase inhibitors | Abran Q. Costales, Jeff Jin, Zuosheng Liu, Sabina Pecchi, Daniel Poon +2 more | 2012-08-14 |
| 8202876 | Compounds and compositions as protein kinase inhibitors | Pamela Albaugh, Gregory B. Chopiuk, Qiang Ding, Zuosheng Liu, Shifeng Pan +10 more | 2012-06-19 |
| 8013153 | Substituted pyrimidine kinase inhibitors | Jeannene Butler, Peter J. Connolly, Angel R. Fuentes-Pesquera, Lee Greenberger, Kenneth R. LaMontagne, Jr. +2 more | 2011-09-06 |
| 7893064 | Hydrazone derivatives as kinase inhibitors | Guozhang Xu, Lily Lee Searle | 2011-02-22 |
| 7888380 | 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives | Ronghui Lin, Peter J. Connolly, Stuart Emanuel, Steven A. Middleton, Robert H. Gruninger +1 more | 2011-02-15 |
| 7855205 | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders | Ronghua Li, Peter J. Connolly, Stuart Emanuel, Steven A. Middleton | 2010-12-21 |
| 7541367 | 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders | George Chiu, Peter J. Connolly, Stuart Emanuel, Shengjian Li, Ronghui Lin +2 more | 2009-06-02 |
| 7317031 | Substituted triazole diamine derivatives as kinase inhibitors | Ronghui Lin, Steven K. Wetter, Peter J. Connolly, Stuart Emanuel, Robert H. Gruninger +1 more | 2008-01-08 |
| 6987189 | Short synthesis of pyridine-based pharmaceutical intermediates | Daniel L. Comins | 2006-01-17 |
| 6924302 | Substituted triazole diamine derivatives as kinase inhibitors | Ronghui Lin, Peter J. Connolly, Steven K. Wetter, Stuart Emanuel, Robert H. Gruninger +1 more | 2005-08-02 |
| 6855825 | Short synthesis of pyridine-based pharmaceutical intermediates | Daniel L. Comins | 2005-02-15 |